4,474 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Purchased by Intech Investment Management LLC

Intech Investment Management LLC purchased a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 4,474 shares of the medical instruments supplier's stock, valued at approximately $815,000.

Several other institutional investors and hedge funds also recently modified their holdings of the business. SG Americas Securities LLC increased its stake in ICU Medical by 441.7% in the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock worth $691,000 after purchasing an additional 4,744 shares in the last quarter. LMR Partners LLP acquired a new stake in shares of ICU Medical in the third quarter worth $3,884,000. Savant Capital LLC acquired a new position in shares of ICU Medical during the 2nd quarter worth about $431,000. Boston Partners bought a new stake in shares of ICU Medical in the first quarter valued at approximately $790,000. Finally, Jane Street Group LLC raised its position in shares of ICU Medical by 79.7% during the first quarter. Jane Street Group LLC now owns 89,852 shares of the medical instruments supplier's stock valued at $9,643,000 after buying an additional 39,839 shares during the last quarter. Institutional investors own 96.10% of the company's stock.

Insider Activity at ICU Medical

In related news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction on Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of the business's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at $18,665,666.78. This trade represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,364 shares of company stock worth $6,876,478 over the last quarter. Company insiders own 6.70% of the company's stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, November 20th. Raymond James raised their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research note on Thursday, September 12th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. KeyCorp raised their price target on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 13th. Finally, Jefferies Financial Group assumed coverage on shares of ICU Medical in a research report on Monday, October 14th. They set a "hold" rating and a $183.00 price target on the stock. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $173.00.

ICU Medical Trading Up 2.6 %

NASDAQ ICUI traded up $4.21 on Friday, hitting $163.96. The company's stock had a trading volume of 159,148 shares, compared to its average volume of 274,156. The company's 50-day moving average is $174.85 and its 200 day moving average is $146.69. The firm has a market cap of $4.01 billion, a PE ratio of -34.96 and a beta of 0.66. ICU Medical, Inc. has a 1-year low of $83.26 and a 1-year high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.